No Summary
Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation - STAT
Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation
Sources
Paywall and unreadable sources
-
Novo Nordisk Ends Heart Disease Drug Trials in Fresh Setback
bloomberg.com
-
Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation
STAT
-
Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped
Fierce Biotech
-
Novo scraps two more heart drug trials, further dimming growth beyond obesity
reuters.com
-
Novo's hopes for ziltivekimab dwindle as two heart failure studies stopped early
FirstWord Pharma